Varaico: Literature-Extracted Genetic Variants

Gene:PRKAR1A
Variant:p.R368*
Back to variants list

PRKAR1A

NM_002734.5:p.R368*

Associated Papers

Molecular Landscape in Limb Anomalies: Diagnostic Yield and New Candidate Genes.

Mokhtari A et al.

Clinical Genetics, 2026

Genetic skeletal disorders: phenotypic-genotypic characteristics and RhGH therapy responses of a pediatric cohort.

Huang Y et al.

Scientific Reports, 2025

40596606 (PubMed )
Supplement: 41598_2025_7570_MOESM2_ESM.xlsx › sheet1

Clinical genome sequencing in patients with suspected rare genetic disease in Peru.

Bazalar-Montoya J et al.

Npj Genomic Medicine, 2024

39468051 (PubMed )
Supplement: 41525_2024_434_MOESM2_ESM.xlsx › Report_Outcomes_and_Variants

Phosphodiesterase 4D activity in acrodysostosis-associated neural pathology: too much or too little?

Gardner OFW et al.

Brain Communications, 2024

Genome-wide CRISPR screening of chondrocyte maturation newly implicates genes in skeletal growth and height-associated GWAS loci.

Baronas JM et al.

Cell Genomics, 2023

37228756 (PubMed )
Supplement: mmc3.pdf

Correction of a knock-in mouse model of acrodysostosis with gene therapy using a rAAV9-CAG-human PRKAR1A vector.

Özgür-Günes Y et al.

Gene Therapy, 2022

Molecular diagnosis in a cohort of 114 patients with rare skeletal dysplasias.

Silveira KC et al.

American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2021

Genetic Determinants of Inherited Endocrine Tumors: Do They Have a Direct Role in Bone Metabolism Regulation and Osteoporosis?

Marini F et al.

Genes, 2021

Expanding the phenotypic spectrum of variants in PDE4D/PRKAR1A: from acrodysostosis to acroscyphodysplasia.

Michot C et al.

European Journal of Human Genetics : Ejhg, 2018

What to consider when pseudohypoparathyroidism is ruled out: iPPSD and differential diagnosis.

Pereda A et al.

Bmc Medical Genetics, 2018

Knock-In of the Recurrent R368X Mutation of PRKAR1A that Represses cAMP-Dependent Protein Kinase A Activation: A Model of Type 1 Acrodysostosis.

Le Stunff C et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2017

Endocrinological and phenotype evaluation in a patient with acrodysostosis.

Ueyama K et al.

Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, 2017

From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network.

Thiele S et al.

European Journal of Endocrinology, 2016

Screening of PRKAR1A and PDE4D in a Large Italian Series of Patients Clinically Diagnosed With Albright Hereditary Osteodystrophy and/or Pseudohypoparathyroidism.

Elli FM et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2016

Pseudohypoparathyroidism and Gsα-cAMP-linked disorders: current view and open issues.

Mantovani G et al.

Nature Reviews. Endocrinology, 2016

Functional Characterization of PRKAR1A Mutations Reveals a Unique Molecular Mechanism Causing Acrodysostosis but Multiple Mechanisms Causing Carney Complex.

Rhayem Y et al.

The Journal of Biological Chemistry, 2015

Impact of kinase activating and inactivating patient mutations on binary PKA interactions.

Röck R et al.

Frontiers in Pharmacology, 2015

Heterozygous mutations in cyclic AMP phosphodiesterase-4D (PDE4D) and protein kinase A (PKA) provide new insights into the molecular pathology of acrodysostosis.

Kaname T et al.

Cellular Signalling, 2014

The first mutation identified in a Chinese acrodysostosis patient confirms a p.G289E variation of PRKAR1A causes acrodysostosis.

Li N et al.

International Journal of Molecular Sciences, 2014

Novel mutations of the PRKAR1A gene in patients with acrodysostosis.

Muhn F et al.

Clinical Genetics, 2013

PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance.

Linglart A et al.

The Journal of Clinical Endocrinology and Metabolism, 2012

Acrodysostosis syndromes.

Silve C et al.

Bonekey Reports, 2012

PRKAR1A mutation affecting cAMP-mediated G protein-coupled receptor signaling in a patient with acrodysostosis and hormone resistance.

Nagasaki K et al.

The Journal of Clinical Endocrinology and Metabolism, 2012

Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis.

Michot C et al.

American Journal of Human Genetics, 2012

Exome sequencing identifies PDE4D mutations in acrodysostosis.

Lee H et al.

American Journal of Human Genetics, 2012

Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance.

Linglart A et al.

The New England Journal of Medicine, 2011

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."